Yong qiang Duan

Dr. Yong qiang Duan


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
MBMin Bai
Min Bai
LZLinna Zhao
Linna Zhao
MLMengya Liu
Mengya Liu
RLRunfa Li
Runfa Li
YYYuping Yang
Yuping Yang
YCYingxia Cheng
Yingxia Cheng

28 August 2025 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
HCHanfei Chen
Hanfei Chen
SZSichao Zhao
Sichao Zhao
PPPeng Pen
Peng Pen
YSYi Shan
Yi Shan
YGYanxia Gong
Yanxia Gong
YDYong qiang Duan
Yong qiang Duan

10 June 2026 in Journal of Chromatography B
Verified
Journal Article
Closed access
YSYi Shan
Yi Shan
JJJin Jin
Jin Jin
YWYiduo Wu
Yiduo Wu
RYRunsheng Yu
Runsheng Yu
YCYingxia Cheng
Yingxia Cheng
YDYong qiang Duan
Yong qiang Duan

16 March 2024 in Heliyon
Verified
Journal Article
Open access
YYYu-Ping Yang
Yu-Ping Yang
MBMin Bai
Min Bai
YCYin-Xia Cheng
Yin-Xia Cheng
XFXin Feng
Xin Feng
YZYan-Ying Zhang
Yan-Ying Zhang
YDYong qiang Duan
Yong qiang Duan
Primary liver cancer (PLC) is a prevalent malignancy of the digestive system characterized by insidious symptom onset and a generally poor prognosis. Recent studies have highlighted a significant correlation between the initiation and prognosis of liver cancer and the immune function of PLC patients. Revealing the expression of PLC-related immune genes and the characteristics of immune cell infiltration provides assistance for the analysis of clinical pathological parameters and prognosis of PLC patients. PLC-related differentially expressed genes (DEGs) with a median absolute deviation (MAD > 0.5) were identified from TCGA and GEO databases. These DEGs were intersected with immune-related genes (IRGs) from the ImmPort database to obtain PLC-related IRGs. The method of constructing a prognostic model through immune-related gene pairs (IRGPs) is used to obtain IRGPs and conduct the selection of central immune genes. The central immune genes obtained from the selection of IRGPs are validated in PLC. Subsequently, the relative proportions of 22 types of immune cells in different immune risk groups are evaluated, and the differential characteristics of PLC-related immune cells are verified through animal experiments. Through database screening and the construction of an IRGP prognosis model, 84 pairs of IRGPs (P < 0.001) were ultimately obtained. Analysis of these 84 IRGPs revealed 11 central immune genes related to PLC, showing differential expression in liver cancer tissues compared to normal liver tissues. Results from the CiberSort platform indicate differential expression of immune cells such as naive B cells, macrophages, and neutrophils in different immune risk groups. Animal experiments demonstrated altered immune cell proportions in H22 tumor-bearing mice, validating findings from peripheral blood and spleen homogenate analyses. Our study successfully predicted and validated PLC-related IRGs and immune cells, suggesting their potential as prognostic indicators and therapeutic targets for PLC.

28 January 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
HJHu Junrui
Hu Junrui
YDYong qiang Duan
Yong qiang Duan
CGCui Gongning
Cui Gongning
LQLuo Qiang
Luo Qiang
XSXi Shanshan
Xi Shanshan
WHWu Hongyan
Wu Hongyan
To investigate the mechanisms and active components governing the anticancer activity of rhubarb.The TCMSP database was screened to identify the active components of rhubarb and Swiss target predictions were generated to predict their cellular targets. TTD and OMIM databases were used to predict tumor-related target genes. "Cytoscape" was used to construct drug targets. PPI network analysis, GO enrichment analysis and KEGG pathway analysis of the key targets were investigated using String and David databases. A total of 33 components and 116 corresponding targets were screened. Amongst them, the key active compounds in rhubarb included emodin, aloe emodin, β-sitosterol, emodin methyl ether and rhein, which were predicted to target TP53, AKT1, STAT3, PIK3CA, HRAS, and VEGFA. GO analysis revealed that the cellular targets clustered into 159 biological processes, including those involved in cellular composition (n=24) and molecular functions (n=42, P<0.01). KEGG pathway analysis revealed 85 (P < 0.01) pathways related to cancer. The active compounds in rhubarb target TP53, AKT1 and PIK3CA. Rhubarb therefore regulates cancer development through an array of biological pathways.